After reviewing the pilot project program in Ghana, Kenya and Malawi that began in 2019, the WHO approved the world's first vaccine for the treatment of malaria.
New York. The World Health Organization (WHO) has approved the use of the world's first vaccine for the treatment of malaria.WHO on Wednesday approved the use of RTS, S/AS01 malaria vaccine. Malaria caused by mosquitoes kills more than 4 lakh people every year, mostly African children.
The WHO has taken this decision after reviewing the pilot project program that started in Ghana, Kenya, and Malawi in 2019.WHO has recommended RTS, S/AS01 malaria vaccine. More than two million doses of the vaccine were given in Ghana, Kenya, and Malawi under the pilot project, which was first produced in 1987 by the pharmaceutical company GSK.
According to the World Health Organization, every two minutes a child dies of malaria. Kate O'Brien, director of the WHO's Department of Immunization, Vaccines, and Biologicals, said the next step would be funding before the new recommended vaccine reaches African children. many livesCould Be Saved WHO General Director Tedros Adhanom Ghebreyesus said after reviewing pilot projects in Ghana, Kenya, and Malawi he is recommending the widespread use of the world's first malaria vaccine. He says that many lives will be saved every year by using it.
The WHO said in a statement that it recommends the widespread use of the vaccine among children with moderate to high malaria transmission in sub-Saharan Africa and other regions. There are currently several vaccines against malaria viruses and bacteria, but this is the first time the WHO has recommended a vaccine against malaria for widespread use.
It is being told that this vaccine works against Plasmodium falciparum, the deadliest type of malaria, which is one of the five parasitic species and the deadliest. Symptoms of malaria include fever, headache and muscle aches, chills, and sweating.